Choom Holdings Inc.

OTC: CHOOF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#566 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ —GM —SS 39

v0.1 · 5/100 weight · pillars only

↑ revenue growth (YoY), Piotroski F · ↓ market scale, balance-sheet leverage

Methodology →

Revenue TTM

$15.2M

Rev growth YoY (TTM)

+11.4%

Net income (FY)

-$16.9M

Employees

Market cap

$4.7k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$17.2M22.0M CAD2021

Net income-$16.9M-21.6M CAD2021

Operating income-$3.8M-4.9M CAD2021

Total assets$21.1M26.2M CAD2021

Liabilities$30.1M37.4M CAD2021

Equity-$9.0M-11.2M CAD2021

Revenue trend

FY2017 – FY2021 · USD

FY17

FY18

$202.7k

FY19

$5.5M

FY20

$17.2M

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Choom Holdings Inc. booked $17.2M in FY2021 revenue, growing 214% year over year — faster than 90% of Healthcare companies we track, at a -98.1% net margin.

Peers · Healthcare

Orthometrix, Inc.——Flower One Holdings Inc.——Sentry Petroleum Ltd——Life Stem Genetics Inc.——

Key facts

CEOTerese Joanne Gieselman

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: CHOOF

Employees40

IPO date2013-02-15

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.